18F-PSMA 1007 Brain PET/CT Imaging in Glioma Recurrence

Area of Science:

• Nuclear medicine
• Oncology
• Radiochemistry

Background:

• Glioblastoma multiforme (GBM) is an aggressive primary brain tumor.
• Recurrence detection in GBM often requires advanced imaging techniques.
• F-FDG PET/CT is a standard imaging modality for cancer staging and recurrence.

Observation:

• A 64-year-old male with a history of right parietal lobe GBM presented with suspected recurrence.
• Both F-FDG PET/CT and F-PSMA 1007 PET/CT scans were performed.
• The right parietal lobe lesion showed intense tracer uptake on both scans, correlating with MRI findings.

Findings:

• Histopathological examination confirmed glioblastoma recurrence.
• F-PSMA 1007 PET/CT demonstrated high tracer uptake in the recurrent GBM lesion.
• The findings suggest F-PSMA 1007 PET/CT is a viable tool for identifying GBM recurrence.

Implications:

• F-PSMA 1007 PET/CT imaging shows promise for diagnosing glioblastoma recurrence.
• Its structural similarity to PSMA-617 suggests potential theranostic applications.
• This could lead to novel targeted therapies for recurrent brain tumors using alpha or beta emitters.